{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:33:04Z","timestamp":1793208784417,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.compbiomed.2023.107657","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T17:30:03Z","timestamp":1698946203000},"page":"107657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Identification of anti-cancer organometallic compounds by inhibition of BCL-2\/Bax interactions"],"prefix":"10.1016","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5668-6038","authenticated-orcid":false,"given":"Mohd","family":"Afzal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Alarifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naaser.A.Y.","family":"Abduh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arusha","family":"Ayub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd.","family":"Muddassir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2023.107657_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bjc.1972.33","article-title":"Apoptosis: a basic biological phenomenon with wideranging implications in tissue kinetics","volume":"26","author":"Kerr","year":"1972","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.compbiomed.2023.107657_bib2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/cdd.2017.183","article-title":"Why do BCL-2 inhibitors work and where should we use them in the clinic?","volume":"25","author":"Montero","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.compbiomed.2023.107657_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nri.2016.153","article-title":"Programmed cell death and the immune system","volume":"17","author":"Nagata","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.compbiomed.2023.107657_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrc2297","article-title":"Diagnosing and exploiting cancer's addiction to blocks in apoptosis","volume":"8","author":"Letai","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.compbiomed.2023.107657_bib5","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1158\/1078-0432.CCR-16-0955","article-title":"Venetoclax in patients with previously treated chronic lymphocytic leukemia","volume":"23","author":"Roberts","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.compbiomed.2023.107657_bib6","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1158\/2159-8290.CD-16-0313","article-title":"Efficacy and biological correlates of response in a phase II study of venetoclax monotherapy in patients with acute myelogenous leukemia","volume":"6","author":"Konopleva","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.compbiomed.2023.107657_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2021.126779","article-title":"Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: limitations, and current and future perspectives","volume":"67","author":"Fasae","year":"2021","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.compbiomed.2023.107657_bib8","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.1039\/c3cc41143e","article-title":"Exploration of the medical periodic table: towards new targets","volume":"49","author":"Barry","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.compbiomed.2023.107657_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jorganchem.2022.122556","article-title":"In silico investigation of organometallic complexes for identification of RNase A inhibitor","volume":"983","author":"Sepay","year":"2023","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.compbiomed.2023.107657_bib10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.compbiomed.2023.107657_bib11","doi-asserted-by":"crossref","DOI":"10.1007\/BF00228148","article-title":"AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR","volume":"8","author":"Laskowski","year":"1996","journal-title":"J. Biomol. NMR"},{"key":"10.1016\/j.compbiomed.2023.107657_bib12","doi-asserted-by":"crossref","DOI":"10.1063\/5.0014475","article-title":"Scalable molecular dynamics on CPU and GPU architectures with NAMD","volume":"153","author":"Phillips","year":"2020","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.compbiomed.2023.107657_bib13","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/jcc.21287","article-title":"CHARMM: the biomolecular simulation program","volume":"30","author":"Brooks","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2023.107657_bib14","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2023.107657_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1039\/B818330A","article-title":"Hirshfeld surface analysis","volume":"11","author":"Spackman","year":"2009","journal-title":"CrystEngComm"},{"key":"10.1016\/j.compbiomed.2023.107657_bib16","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2023.107657_bib17","doi-asserted-by":"crossref","first-page":"24178","DOI":"10.1039\/D2RA04333E","article-title":"Identification of 4-acrylamido- N -(pyridazin-3-yl)benzamide as anti-COVID-19 compound: a DFTB, molecular docking, and molecular dynamics study","volume":"12","author":"Sepay","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.compbiomed.2023.107657_bib18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1021\/ct100641a","article-title":"NCIPLOT: a program for plotting noncovalent interaction regions","volume":"7","author":"Contreras-Garc\u00eda","year":"2011","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.compbiomed.2023.107657_bib19","series-title":"Gaussian 09, Revision D.01","article-title":"2009 Gaussian 09, revision D.01; Gaussian, inc.: wallingford, CT","year":"2009"},{"key":"10.1016\/j.compbiomed.2023.107657_bib20","series-title":"2009. GaussView, Version 5; Gaussian, Inc.: Wallingford, CT","year":"2009"},{"key":"10.1016\/j.compbiomed.2023.107657_bib21","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1021\/ct900587b","article-title":"Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field","volume":"6","author":"Shivakumar","year":"2010","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.compbiomed.2023.107657_bib22","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.compbiomed.2023.107657_bib23","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1063\/1.463940","article-title":"Nos\u00e9\u2013Hoover chains: the canonical ensemble via continuous dynamics","volume":"97","author":"Martyna","year":"1992","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.compbiomed.2023.107657_bib24","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1063\/1.467468","article-title":"Constant pressure molecular dynamics algorithms","volume":"101","author":"Martyna","year":"1994","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.compbiomed.2023.107657_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0010-4655(96)00016-1","article-title":"Ewald summation techniques in perspective: a survey","volume":"95","author":"Toukmaji","year":"1996","journal-title":"Comput. Phys. Commun."},{"key":"10.1016\/j.compbiomed.2023.107657_bib26","doi-asserted-by":"crossref","first-page":"13396","DOI":"10.1039\/C9DT00143C","article-title":"Synthesis, characterization and biological evaluation of cationic organoruthenium(II) fluorene complexes: influence of the nature of the counteranion","volume":"48","author":"Haghdoost","year":"2019","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.compbiomed.2023.107657_bib27","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1039\/c2sc20220d","article-title":"The contrasting chemical reactivity of potent isoelectronic iminopyridine and azopyridine osmium(ii) arene anticancer complexes","volume":"3","author":"Fu","year":"2012","journal-title":"Chem. Sci."},{"key":"10.1016\/j.compbiomed.2023.107657_bib28","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1039\/c1cc10167f","article-title":"Hexanuclear self-assembled arene-ruthenium nano-prismatic cages: potential anticancer agents","volume":"47","author":"Vajpayee","year":"2011","journal-title":"Chem. Commun."},{"key":"10.1016\/j.compbiomed.2023.107657_bib29","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1039\/D1DT02765D","article-title":"Ru(III) complexes with pyrazolopyrimidines as anticancer agents: bioactivities and the underlying mechanisms","volume":"51","author":"Gu","year":"2022","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.compbiomed.2023.107657_bib30","doi-asserted-by":"crossref","first-page":"12810","DOI":"10.1039\/C7CC08270C","article-title":"Half-sandwich ruthenium(II) complexes containing N^N-chelated imino-pyridyl ligands that are selectively toxic to cancer cells","volume":"53","author":"Tian","year":"2017","journal-title":"Chem. Commun."},{"key":"10.1016\/j.compbiomed.2023.107657_bib31","doi-asserted-by":"crossref","first-page":"6870","DOI":"10.1039\/C7DT00575J","article-title":"Half-sandwich iridium N-heterocyclic carbene anticancer complexes","volume":"46","author":"Wang","year":"2017","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.compbiomed.2023.107657_bib32","doi-asserted-by":"crossref","first-page":"15520","DOI":"10.1039\/C7DT03265J","article-title":"Novel half-sandwich iridium(III) imino-pyridyl complexes showing remarkable in vitro anticancer activity","volume":"46","author":"Li","year":"2017","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.compbiomed.2023.107657_bib33","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1039\/C7SC05058E","article-title":"New activation mechanism for half-sandwich organometallic anticancer complexes","volume":"9","author":"Banerjee","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.compbiomed.2023.107657_bib34","doi-asserted-by":"crossref","first-page":"16183","DOI":"10.1039\/C8NJ03360A","article-title":"Electronic effects on reactivity and anticancer activity by half-sandwich N,N-chelated iridium(III) complexes","volume":"42","author":"Guo","year":"2018","journal-title":"New J. Chem."},{"key":"10.1016\/j.compbiomed.2023.107657_bib35","doi-asserted-by":"crossref","first-page":"38629","DOI":"10.1039\/C9RA08736B","article-title":"Anticancer and antimicrobial properties of novel \u03b7 6 - p -cymene ruthenium(ii) complexes containing a N,S-type ligand, their structural and theoretical characterization","volume":"9","author":"Namieci\u0144ska","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.compbiomed.2023.107657_bib36","doi-asserted-by":"crossref","first-page":"7345","DOI":"10.1039\/c003085f","article-title":"Osmium(II)\u2013versus ruthenium(II)\u2013arene carbohydrate-based anticancer compounds: similarities and differences","volume":"39","author":"Hanif","year":"2010","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.compbiomed.2023.107657_bib37","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1039\/D0SC00897D","article-title":"Ligand-centred redox activation of inert organoiridium anticancer catalysts","volume":"11","author":"Zhang","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.compbiomed.2023.107657_bib38","doi-asserted-by":"crossref","first-page":"19314","DOI":"10.1039\/C5DT02410B","article-title":"Antimalarial activity of ruthenium(II) and osmium(II) arene complexes with mono- and bidentate chloroquine analogue ligands","volume":"44","author":"Ekengard","year":"2015","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.compbiomed.2023.107657_bib39","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1039\/C5DT03739E","article-title":"Pentamethylcyclopentadienyl-rhodium and iridium complexes containing (N^N and N^O) bound chloroquine analogue ligands: synthesis, characterization and antimalarial properties","volume":"45","author":"Ekengard","year":"2016","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.compbiomed.2023.107657_bib40","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1039\/C7DT00439G","article-title":"Comparative solution equilibrium studies of antitumor ruthenium(\u03b7 6 -p-cymene) and rhodium(\u03b7 5 -C 5 Me 5) complexes of 8-hydroxyquinolines","volume":"46","author":"D\u00f6m\u00f6t\u00f6r","year":"2017","journal-title":"Dalt. Trans."},{"key":"10.1016\/j.compbiomed.2023.107657_bib41","doi-asserted-by":"crossref","first-page":"11174","DOI":"10.1039\/C8NJ01681J","article-title":"Structural and solution equilibrium studies on half-sandwich organorhodium complexes of (N,N) donor bidentate ligands","volume":"42","author":"M\u00e9sz\u00e1ros","year":"2018","journal-title":"New J. Chem."},{"key":"10.1016\/j.compbiomed.2023.107657_bib42","doi-asserted-by":"crossref","first-page":"12016","DOI":"10.1039\/C9CC03822A","article-title":"Anticancer organorhodium and -iridium complexes with low toxicity in vivo but high potency in vitro : DNA damage, reactive oxygen species formation, and haemolytic activity","volume":"55","author":"Parveen","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.compbiomed.2023.107657_bib43","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1039\/D0QI00538J","article-title":"Anticancer potency of novel organometallic Ir(III) complexes with phosphine derivatives of fluoroquinolones encapsulated in polymeric micelles","volume":"7","author":"Kozie\u0142","year":"2020","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.compbiomed.2023.107657_bib44","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1039\/D1SC01939B","article-title":"Osmium(II) tethered half-sandwich complexes: pH-dependent aqueous speciation and transfer hydrogenation in cells","volume":"12","author":"Infante-Tadeo","year":"2021","journal-title":"Chem. Sci."},{"key":"10.1016\/j.compbiomed.2023.107657_bib45","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1039\/b303745b","article-title":"Can an in silico drug-target search method be used to probe potential mechanisms of medicinal plant ingredients?","volume":"20","author":"Chen","year":"2003","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.compbiomed.2023.107657_bib46","series-title":"Silico Drug Des.","first-page":"19","article-title":"Computational drug design methods\u2014current and future perspectives","author":"Prieto-Mart\u00ednez","year":"2019"},{"key":"10.1016\/j.compbiomed.2023.107657_bib47","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.1039\/D2CP00082B","article-title":"Crystallography-based exploration of non-covalent interactions for the design and synthesis of coumarin for stronger protein binding","volume":"24","author":"Sepay","year":"2022","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.compbiomed.2023.107657_bib48","doi-asserted-by":"crossref","first-page":"7261","DOI":"10.1039\/D0CP05714B","article-title":"A crystallography-based investigation of weak interactions for drug design against COVID-19","volume":"23","author":"Sepay","year":"2021","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.compbiomed.2023.107657_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.129433","article-title":"Anti-COVID-19 terpenoid from marine sources: a docking, admet and molecular dynamics study","volume":"1228","author":"Sepay","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.compbiomed.2023.107657_bib50","doi-asserted-by":"crossref","first-page":"9735","DOI":"10.1039\/D2NJ00389A","article-title":"Identification of natural flavonoids as novel EGFR inhibitors using DFT, molecular docking, and molecular dynamics","volume":"46","author":"Sepay","year":"2022","journal-title":"New J. Chem."},{"key":"10.1016\/j.compbiomed.2023.107657_bib51","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/cdd.2008.137","article-title":"Bcl-2 inhibitors: small molecules with a big impact on cancer therapy","volume":"16","author":"Vogler","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.compbiomed.2023.107657_bib52","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1038\/s41598-023-33024-2","article-title":"MasitinibL shows promise as a drug-like analog of masitinib that elicits comparable SARS-Cov-2 3CLpro inhibition with low kinase preference","volume":"13","author":"Durojaye","year":"2023","journal-title":"Sci. Rep."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482523011228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482523011228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:48:35Z","timestamp":1793206115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482523011228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":52,"alternative-id":["S0010482523011228"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2023.107657","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of anti-cancer organometallic compounds by inhibition of BCL-2\/Bax interactions","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2023.107657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107657"}}